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Expression of replication-dependent histone genes at the posttranscriptional level is controlled by stem-loop
binding protein (SLBP). One function of SLBP is to bind the stem-loop structure in the 3* untranslated region of
histone pre-mRNAs and facilitate 3* end processing. Interaction of SLBP with the stem-loop is mediated by the
centrally located RNA binding domain (RBD). Here we identify several highly conserved amino acids in the
RBD mutation of which results in complete or substantial loss of SLBP binding activity. We also identify
residues in the RBD which do not contribute to binding to the stem-loop RNA but instead are required for
efficient recruitment of U7 snRNP to histone pre-mRNA. Recruitment of the U7 snRNP to the pre-mRNA also
depends on the 20-amino-acid region located immediately downstream of the RBD. A critical region of the RBD
contains the sequence YDRY. The tyrosines are required for RNA binding, and the DR dipeptide is essential
for processing but not for RNA binding. It is likely that the RBD of SLBP interacts directly with both the
stem-loop RNA and other processing factor(s), most likely the U7 snRNP, to facilitate histone pre-mRNA
processing.
Replication-dependent histone genes comprise a unique
group of genes whose expression is coordinately regulated with
DNA synthesis (15). Expression of these genes peaks during S
phase of the cell cycle and rapidly declines upon completion of
DNA replication at the end of S phase (10, 30). In contrast to
all other mRNAs, replication-dependent histone mRNAs are
not polyadenylated and instead terminate with a highly con-
served stem-loop structure (15). The stem-loop structure, con-
sisting of six base pairs and a four nucleotide loop, associates
with a protein termed the stem-loop binding protein (SLBP) or
the hairpin binding protein (14, 29). Mammalian SLBP is a
30-kDa protein containing 270 amino acids and can be divided
into three domains: the centrally located RNA binding domain
(RBD) and the flanking N-terminal and C-terminal domains.
The RBD of SLBP does not resemble any previously identified
motifs involved in RNA recognition (29).
Replication-dependent histone mRNAs are formed from
longer pre-mRNA transcripts by an endonucleolytic cleavage
(3, 8). The processing reaction depends on two sequence ele-
ments in the histone pre-mRNA: the stem-loop structure (27)
and a purine-rich element, termed the histone downstream
element (HDE), located 10 to 15 nucleotides further down-
stream (2). The stem-loop is recognized by SLBP, whereas the
HDE associates with the U7 snRNP, containing the 60-nucle-
otide U7 snRNA and associated proteins (20, 22). Binding of
U7 snRNP to the pre-mRNA occurs via base pairing between
the HDE and the 59 end of U7 snRNA (2, 18) and is likely also
strengthened by interactions between a U7-specific protein(s)
and the SLBP–stem-loop (SLBP/SL) complex (5). This addi-
tional interaction is especially important in processing of his-
tone pre-mRNAs containing HDEs which can form only a
weak duplex with the U7 snRNA and thus are unable to effi-
ciently recruit U7 snRNP to the pre-mRNA (5, 17, 23). Stable
binding of SLBP and U7 snRNP to their respective targets in
the pre-mRNA leads to a subsequent association of additional
trans-acting factors, including a poorly characterized heat-la-
bile factor (9), followed by cleavage of the pre-mRNA four to
five nucleotides downstream from the stem-loop. After 39 end
processing, SLBP remains associated with the terminal stem-
loop and assists the mature histone mRNA to the cytoplasm,
where it likely plays an important role in histone mRNA trans-
lation and stability (7, 25, 31). SLBP is cell cycle regulated and
therefore may be a key factor responsible for cell cycle regu-
lation of histone mRNA levels (30).
Two proteins that bind the stem-loop structure at the 39 end
of histone mRNA have been isolated from Xenopus laevis
oocytes (28). One protein, referred to as xSLBP1, is homolo-
gous to mammalian SLBPs and is also involved in 39 end
processing of histone pre-mRNAs. A second SLBP found in
Xenopus oocytes, designated xSLBP2, does not participate in
39 end processing and probably functions in storage of histone
mRNA during oogenesis (28). xSLBP2 is similar to xSLBP1
only in the central RBD. Replacement of the RBD of xSLBP1
with the corresponding domain of xSLBP2 resulted in a chi-
meric protein that retained high affinity for the stem-loop.
Surprisingly, this chimeric protein was inactive in processing
although it contains the C-terminal region from xSLBP1 re-
quired for processing (11). Thus, binding to the stem-loop of
histone pre-mRNA is not the only function of the RBD in 39
end processing. Here we identify residues in the RBD of hu-
man SLBP that are not required for binding to the RNA target
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and instead play another role in processing. Our experiments
indicate that these residues together with the 20-amino-acid
region in the C terminus are each important for efficient re-
cruitment of the U7 snRNP to the histone pre-mRNA. In
addition, by aligning RBD sequences of various SLBPs, we
identified absolutely conserved amino acids and demonstrated
that these residues are required for binding to the stem-loop
RNA. Changes in some of these residues results in a reduction
in affinity for the stem-loop, accompanied by a decrease in
processing activity, demonstrating the importance of high-af-
finity binding of SLBP to the stem-loop for efficient 39 end
processing.
MATERIALS AND METHODS
Construction of the mutant and chimeric SLBP clones. Substitutions of the
amino acid residues within the RBD of SLBP were carried out in the pGEM3
vector containing the human SLBP cDNA spanning from the initiation codon to
the MscI site in the 39 untranslated region, 57 nucleotides downstream from the
stop codon. Substitution of these residues was facilitated by the presence of the
following unique restriction sites located within the cDNA region encoding the
RBD: NgoMIV, MfeI, BsmI, SalI, and BamHI. The appropriate restriction frag-
ments in the wild-type SLBP cDNA were replaced by double-stranded oligonu-
cleotides terminating with compatible sticky ends and containing the desired
mutations. The following combinations of restriction enzymes were used during
mutagenesis: NgoMIV and MfeI (to insert mutations located between amino
acids 1 and 21), MfeI and BsmI (to insert mutations located between amino acids
22 and 39), BsmI and SalI (to insert mutations located between amino acids 40
and 52), and SalI and BamHI (to insert mutations located between amino acids
53 and 72). To facilitate identification of the desired clones, where possible,
oligonucleotides were designed so that one of the two restriction sites was
disrupted upon ligation of the insert into the pGEM3 vector, without changing
the amino acid sequence of the RBD. The double mutants QPF, RHLF, QPQVA,
and RHLQVA were constructed by recombining appropriate fragments contain-
ing the individual mutations. Details of each construct and sequences of the
oligonucleotides are available on request. For in vitro protein synthesis, the
SLBP cDNAs containing appropriate mutations were subcloned into the pSP64T
vector. This vector was modified from the pSP64 Poly(A) vector (Promega) by
introducing the 59 and 39 untranslated regions from the rabbit b-globin gene and
a fragment encoding the poly(A) tail (12). The mutant SLBP cDNAs were
inserted into the pSP64T vector downstream from the 59 untranslated region
using NcoI and XbaI restriction sites. For expression of the mutant forms of
SLBP in Sf9 insect cells using the Bac-TO-Bac expression system, mutant cDNAs
were cloned into one of the pFastBac vectors (Gibco-BRL).
Synthesis of SLBP by in vitro translation. The in vitro coupled transcription
and translation reaction was carried out in the rabbit reticulocyte extract using a
Promega TnT kit according to the manufacturer’s protocol. Each reaction (total
volume of 25 ml) contained 12.5 ml of the extract, 5 U of SP6 RNA polymerase
(Promega), and 1.0 mg of the DNA template encoding either the wild-type or
mutant version of the human SLBP subcloned into the pSP64T vector. To
determine the amount of SLBP made during the TnT reactions, the samples
were supplemented with [35S]methionine (NEN) and analyzed by sodium dode-
cyl sulfate (SDS)-polyacrylamide gel electrophoresis.
Expression and purification of SLBP using the baculovirus system. The wild-
type and mutant forms of SLBP were expressed in Sf9 insect cells using the
Bac-TO-Bac baculovirus expression system (Gibco-BRL) as recommended by the
manufacturer. The His-tagged proteins were purified by affinity chromatography
on Ni-nitrilotriacetic acid agarose (Qiagen).
Mobility shift assay. The ability to bind the histone stem-loop RNA by the
mutant SLBP proteins synthesized either in vitro using the TnT kit or in vivo
using the baculovirus system was determined by band shift assay as previously
described (5, 11). Routinely, 2.5 ml of the TnT reaction or 0.1 mg of the protein
expressed in the baculovirus-infected cells was mixed on ice in a total volume of
10 ml with 100 fmol of the 59-labeled stem-loop RNA, 20 mM EDTA, and 2.5 ml
of buffer D used for dialysis of the nuclear extract (20 mM HEPES-KOH [pH
7.9], 100 mM KCl, 0.5 mM dithiothreitol, 0.2 mM EDTA [pH 8.0], 20% glycerol).
The samples were immediately resolved on a 7.5% native polyacrylamide gel
(37.5 parts of acrylamide to 1 part of bisacrylamide) containing Tris-borate-
EDTA buffer. The gel was dried, and radioactive bands were detected by auto-
radiography and/or by PhosphorImager.
Preparation of RNA. In vitro 39 end processing was carried out using 86-
nucleotide pre-mRNAs containing the stem-loop structure and the U7 binding
site from either the H2a-614 or H1t pre-mRNA. A 30-nucleotide RNA contain-
ing the wild-type stem-loop structure and the 5-nucleotide flanks was used in the
band shift assay. Sequences of all three RNA species and methods for their
synthesis and labeling were described previously (5). The U7 snRNA was de-
tected by hybridization with the anti-U7 RNA probe, synthesized, and labeled as
described elsewhere (5).
Preparation of nuclear extract and 3* end processing. Preparation of the
nuclear extract from mouse myeloma cells, immunodepletion of the SLBP, and
complementation of the depleted extract with the recombinant SLBP were per-
formed according to protocols described previously (4, 5, 16). Each processing
reaction contained 5 ml of the nuclear extract corresponding to approximately 50
mg of total protein, 180 fmol of the pre-mRNA substrate labeled at the 59 end
with [g-32P]ATP, and 20 mM EDTA. Samples were incubated at 32°C for 1 h and
processed as previously described (5).
Western blots. Nuclear protein (50 mg) was resolved on an SDS–12% poly-
acrylamide gel and transferred to a nitrocellulose membrane. SLBP was detected
with an antibody raised against the C-terminal 13 amino acids of the protein
using an enhanced chemiluminescence system.
Immunoprecipitation of processing complexes. Processing complexes contain-
ing the U7 snRNP were formed and subsequently precipitated by anti-SLBP
essentially as described elsewhere (5). Each reaction contained 50 ng of unla-
beled pre-mRNA substrate, 50 ml of the nuclear extract, and 20 mM EDTA (pH
8) in a total volume of 100 ml and was supplemented with 0.01 to 0.1 ng of the
substrate labeled at the 59 end with [g-32PO4]ATP (500 to 5,000 cpm respective-
ly). The radiolabeled pre-mRNA was used to monitor the overall efficiency of
immunoprecipitation of the pre-mRNA substrate by the SLBP antibody. In some
experiments, the SLBP-depleted nuclear extract supplemented with different
recombinant SLBPs was used instead of the undepleted nuclear extract. In all
cases, the reaction samples were prepared on ice followed by a short (3- to 5-min)
incubation at 22°C to allow formation of the processing complexes. The affinity-
purified SLBP antibody (10 ml at 1.0 mg/ml) was subsequently added to each
reaction, and the samples were rotated at 4°C for 1.5 h and then transferred to
a new tube containing 15 ml of protein A-agarose beads (Gibco-BRL). Prior to
use, the protein A-agarose beads were incubated for 2 h in an extract from sea
urchin blastula nuclei (containing a U7 snRNA which does not cross-react with
the anti-mouse U7 snRNA probe), to reduce nonspecific binding of components
of the mouse nuclear extract. Subsequent steps in the immunoprecipitation
procedure and Northern blot analysis of U7 snRNA were performed as previ-
ously described (5).
RESULTS
Amino acids conserved in the RBDs of all SLBPs are in-
volved in RNA recognition. In Xenopus oocytes there are two
different SLBPs, xSLBP1 and xSLBP2, which bind the stem-
loop structure at the 39 end of replication-dependent histone
mRNAs with the same affinity (28). xSLBP1 is a homologue of
human and mouse SLBPs and is involved in processing of
histone pre-mRNAs in the nucleus. Similar to mammalian
SLBPs, xSLBP1 is also found in the cytoplasm, where it may
function in regulating translation of histone mRNA. xSLBP2 is
found only in the cytoplasm and is inactive in 39 end processing
of histone pre-mRNA both in vivo and in vitro. Expression of
xSLBP2 is restricted to oogenesis and the protein is degraded
during oocyte maturation, indicating that xSLBP2 may func-
tion in translational repression of histone mRNA (28). This
protein shares amino acid similarity with processing-specific
SLBPs only within the central RBD.
Figure 1A presents a sequence alignment of the 73-amino-
acid RBD from human SLBP, both Xenopus SLBPs, and Dro-
sophila SLBP (24). In the four SLBPs, 36 of the 73 amino acids
of the RBD are identical and 13 other amino acids are re-
placed by similar residues. The strong evolutionary conserva-
tion of these amino acids suggested that they are all involved in
recognition of the common target for each protein; the stem-
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loop structure at the 39 end of histone mRNAs. We tested this
hypothesis by substituting some of the conserved amino acids
with either similar, neutral, or biochemically different residues
(Fig. 1B) and by determining the relative binding affinity of
mutant proteins in the band shift assay. All mutant proteins
were expressed in the presence of [35S]methionine using the
TnT system (Promega) and resolved by SDS-polyacrylamide
gel electrophoresis (Fig. 2, top row of each panel). The gels
were used for autoradiography and PhosphorImager analysis,
allowing precise monitoring of both the quality of SLBP syn-
thesized in vitro (e.g., presence of possible prematurely termi-
nated or improperly initiated products) and the quantity of the
full-length protein subsequently used for the band shift assay.
All mutant SLBPs were generated in vitro at relatively low
concentrations and are likely to be properly folded in the
reticulocyte extract. This approach ensured that any changes in
the ability to shift the RNA probe likely resulted from differ-
ences in the binding affinity between the tested mutant pro-
teins. All amino acids subjected to mutagenesis, with the ex-
ception of the tryptophan at position 56, which is replaced by
phenylalanine in Drosophila melanogaster SLBP, are absolutely
conserved in the four SLBPs shown in Fig. 1A.
The wild-type human SLBP expressed in vitro using the TnT
system efficiently binds to the stem-loop RNA probe. As shown
in Fig. 2, 10% of the entire TnT reaction consistently shifted
between 75 and 90% of the RNA probe. The complex formed
by the SLBP expressed in the reticulocyte lysate has a mobility
identical to that of the complex formed in nuclear extracts (29)
or with baculovirus protein (not shown). As determined by the
same assay, replacement of the two conserved arginines at
positions 10 and 11 of the RBD with lysines (RR/KK mutant)
completely abolished binding to the stem-loop RNA probe (SL
probe) (Fig. 2A, lane 3). No band corresponding to the
SLBP/SL complex was detected even after a long exposure of
the film (not shown). Arginines 10 and 11 are adjacent to a
conserved QKQ tripeptide at positions 12 to 14 of the RBD.
Substitution of this tripeptide with alanines resulted in a pro-
tein (QKQ mutant) that was unable to bind the stem-loop
RNA (Fig. 2A, lane 4). Lysine 19 is absolutely conserved in all
known SLBPs, including those of sea urchin, Caenorhabditis
elegans (13), and Chlamydomonas (unpublished results). Inter-
estingly, changing this amino acid to arginine did not reduce
binding to the stem-loop RNA (K19R mutant) (Fig. 2A, lane
5; Fig. 2B, lane 3). However, replacing lysine 19 with a neutral
residue, alanine, resulted in a protein severely impaired in
stem-loop RNA binding (Fig. 2B, lane 2).
In addition to changing the basic residues and the QKQ
tripeptide, we mutated two sets of conserved aromatic resi-
FIG. 1. Conserved amino acids within the RBD of the SLBP. (A)
Schematic of the vertebrate SLBPs, with the position of the RBD
indicated. The RBDs of the human, two X. laevis, and Drosophila (Fly)
SLBPs were aligned. The amino acids conserved in all four proteins
are highlighted and the residues subjected to mutagenesis are under-
lined. N-ter and C-ter, N and C termini. (B) Amino acid substitutions
made within the RBD of the human SLBP and their relative effect on
binding to the RNA stem-loop structure. The binding affinity of each
mutant SLBP is reported as a percentage of wild-type (WT) binding
affinity (100%). The values represent the range of affinities obtained
from at least two independent experiments.
FIG. 2. The conserved amino acids in the RBD are required for
efficient binding of the protein to the stem-loop structure. Wild-type
(WT) and mutant forms of the human SLBP containing various amino
acid substitutions of the conserved residues, as indicated above each
lane and listed in Fig. 1, were synthesized in vitro using the rabbit
reticulocyte TnT system (Promega) and analyzed by electrophoresis in
SDS–10% polyacrylamide gels (top). Each mutant protein was subse-
quently tested for binding efficiency in the band shift assay using the
30-nucleotide stem-loop RNA labeled at the 59 end as a probe (bot-
tom). Lane 1 of panels A and C represents a negative control in which
the TnT reaction was carried out in the absence of exogenous DNA.
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dues, the two tryptophans at positions 56 and 63 and the two
tyrosines at positions 24 and 27. As determined by the band
shift assay, replacement of the two tryptophans with isoleucines
produced an SLBP mutant unable to bind the stem-loop structure
(WW/II mutant) (Fig. 2A, lane 7). A very conservative mutation
replacing the two tyrosines at position 24 and 27 with phenylala-
nines (YY/FF mutant) resulted in a protein that retains only 5 to
10% of the wild-type binding affinity (Fig. 2A, lane 6; Fig. 2C, lane
3). Replacement of the same tyrosines with either serines (YY/SS
mutant) or threonines (YY/TT mutant), other amino acids con-
taining an OH group, abolished binding (Fig. 2C, lane 4 or 5,
respectively). We next made two single mutations by individually
substituting each tyrosine with phenylalanine. The tyrosine at
position 24 is more important for RNA recognition, since replace-
ment of this residue with phenylalanine (Y24F mutant) resulted
in a more severe decrease in binding than the same replacement
of the tyrosine at position 27 (Y27F mutant). The Y24F and
Y27F SLBPs retained less than 10 and approximately 50%, re-
spectively, of the wild-type binding efficiency (Fig. 2C, lanes 6 and
7). Binding of SLBP to the stem-loop RNA was also dramatically
reduced by replacing histidine at position 41 with phenylalanine
(H41F mutant) (Fig. 2C, lane 8). The effect of this mutation on
binding was similar to that of the Y24F mutation.
Complementation of the SLBP-depleted nuclear extract
with mutant SLBPs. We and others have previously shown that
high-affinity binding of SLBP to the stem-loop structure in
histone pre-mRNA is critically important for efficient 39 end
processing of histone pre-mRNA (5, 17, 19, 27). Mutations of
the stem-loop structure that reduced SLBP binding more than
10-fold resulted in a complete inhibition of processing. Other
changes in the stem-loop reducing affinity to SLBP 5- to 10-
fold had a less drastic effect on the efficiency of 39 end pro-
cessing (5, 19). Here we address whether processing efficiency
is affected in the same fashion by changes in SLBP that de-
crease its affinity for histone pre-mRNA. Using the baculovirus
expression system, we expressed three mutant SLBPs that had
reduced binding activity and evaluated their ability to rescue
processing activity of the SLBP-depleted nuclear extract. As
determined by Western blotting, immunodepletion of the nu-
clear extract with the SLBP antibody resulted in complete
removal of the protein (Fig. 3A, lane 2). We used a histone
pre-mRNA containing the HDE from the H1t gene, since
processing of this pre-mRNA is completely dependent on
SLBP (5). Incubation of H1t pre-mRNA in the nuclear extract
resulted in processing of 75% of the input pre-mRNA, and
removal of SLBP from the extract abolished processing (Fig.
3B, top, lanes 1 and 2, respectively). Addition of 100 ng of
recombinant wild-type SLBP restored processing of the H1t
substrate to the initial level (Fig. 3B, top, lane 3). A similar
increase in processing efficiency was achieved upon addition of
the Y27F mutant SLBP, which binds the stem-loop about 50%
as efficiently as the wild-type protein (Fig. 3B, top, lane 5).
Addition of the same amount of the weakly binding Y24F
mutant protein did not stimulate processing, and addition of
the H41F mutant protein, which has similar stem-loop binding
activity, resulted in accumulation of only a trace amount of the
cleavage product (Fig. 3B, top, lanes 4 and 6, respectively).
These results are consistent with our earlier studies in which
weakening the interaction between SLBP and the RNA by
mutations in the stem-loop structure resulted in a decrease in
processing efficiency both in vivo (19) and in vitro (5). The fact
that the Y27F mutant SLBP does not significantly affect the
processing efficiency of SLBP in spite of a twofold reduction in
RNA binding suggests that there is a threshold level of affinity
above which processing occurs with maximal efficiency.
We tested the same proteins for their ability to restore pro-
cessing of the H2a-614 pre-mRNA, which contains an HDE
capable of forming a relatively strong duplex (12 base pairs
interrupted by only one mismatch) with the 59 end of U7
snRNA. Depending on the batch of nuclear extract used, this
processing substrate is cleaved in vitro with 10 to 20% effi-
ciency even in the absence of SLBP (Fig. 3B, bottom, lane 2;
references 4 and 29). The basal level of processing was ele-
vated to virtually 100% by addition of either the wild-type
SLBP or the Y27F mutant protein (Fig. 3B, bottom, lanes 3
and 5, respectively). The Y24F mutant protein did not stimu-
late processing of the H2a pre-mRNA substrate (Fig. 3B, lane
4). Surprisingly, the H41F SLBP increased processing of the
H2a-614 pre-mRNA as much as fivefold (Fig. 3B, bottom, lane
6), although it has similar affinity for the stem-loop as Y24F
SLBP. It is likely that the region of SLBP around tyrosine 24
may be involved in both RNA binding and other interactions
essential for processing (see below).
Residues in the RBD essential for processing. We have
previously shown that replacement of the RBD from xSLBP2
in xSLBP1 resulted in a protein, 1-2-1, that binds the stem-loop
with the same affinity as xSLBP1 but is inactive in processing,
both in frog oocytes and in vitro (11). Thus, the RBD must
have other functions in histone pre-mRNA processing in ad-
dition to binding the pre-mRNA. Here we define residues in
the RBD that are important for efficient histone pre-mRNA
processing in vitro. The RBDs of SLBP from more distantly
FIG. 3. High-affinity stem-loop binding is required for efficient pro-
cessing of histone H1t pre-mRNA but not H2a pre-mRNA. (A) The
nuclear extract (NE) was immunodepleted of SLBP using the SLBP
antibody, and the efficiency of depletion was determined by Western
blotting carried out with the same antibody (lane 2). Lane 1 represents
an undepleted control nuclear extract. The asterisk indicates a protein
that cross-reacts with the SLBP antibody when denatured but not in
the nuclear extract and serves as a control for specificity of depletion.
The position of a 52.5-kDa marker is indicated. (B) Ability of wild-type
(WT) and mutant forms of SLBP with reduced binding activity to
support processing of the H1t (top) and H2a (bottom) pre-mRNAs.
The indicated mutant proteins were expressed in the baculovirus sys-
tem and used to complement the SLBP-deleted nuclear extract. The
processing activity of the nuclear extract before and after depletion is
shown in lanes 1 and 2, respectively. The uncut band corresponds to
the input histone pre-mRNA, and the cut band corresponds to the
mature product of 39 end processing.
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related metazoans, C. elegans, and D. melanogaster, also do not
substitute for the mammalian RBD in histone pre-mRNA pro-
cessing (unpublished results). This is likely due to incompati-
bility of the vertebrate and invertebrate processing machiner-
ies as has been shown for Xenopus and sea urchins (6). Thus,
the SLBP sequences from C. elegans and D. melanogaster were
not informative in identification of amino acids required for
processing.
There are 15 identical and 2 similar amino acids (highlighted
in Fig. 4A) in the human SLBPs and xSLBP1 which are dif-
ferent in xSLBP2. Of the 15 identical residues, 10 are clustered
between amino acids 22 and 38 of the RBD, while 3 of the
remaining 5 are in the C-terminal portion of the RBD. The
absence of all or some of these amino acids in the chimeric
protein 1-2-1 must be responsible for its inability to function in
39 end processing in spite of efficient binding to the histone
pre-mRNA. To determine which of these 17 amino acids are
critical for 39 end processing, we systematically mutated most
of them either individually or in small groups in the human
SLBP and tested the ability of the mutant proteins to bind
RNA and to restore processing to an SLBP-depleted extract.
We replaced the amino acids in human SLBP with the amino
acids found in the same position in xSLBP2, since these resi-
dues are likely to be neutral for RNA binding (Fig. 4). In the
first round of this scanning mutagenesis, we altered nine amino
acids near the center of the RBD (9aaR mutation). In addi-
tion, we replaced the phenylalanine at position 48 with serine
(F48S mutation) and the QVA in the C-terminal part of the
RBD with MRD (QVA mutation). As determined by band
shift assay, all of the mutant proteins expressed in baculovirus-
infected insect cells efficiently bound to the stem-loop RNA
(Fig. 5A). Subsequently, the same preparation of each mutant
SLBP was tested for the ability to restore in vitro processing
activity to the SLBP-depleted nuclear extract using the H1t
histone pre-mRNA substrate. In each experiment, approxi-
mately 100 ng of the baculovirus-expressed SLBP was added to
the depleted extract. This amount of protein is sufficient to
bind the vast majority of the input substrate (not shown). The
9aaR mutant protein was completely inactive in processing of
the H1t histone pre-mRNA (Fig. 5B, lane 4), demonstrating
that the 14-residue region from amino acids 25 to 38 of the
human RBD is critical for processing. The F48S and QVA
mutant proteins complemented the depleted extract as effi-
ciently as the wild-type SLBP (Fig. 5B, lanes 5 and 6, respec-
tively). We next prepared a second set of mutations by altering
a small number of the amino acids within the 14-amino-acid
cluster. The DR dipeptide at positions 25 and 26 that is flanked
by the two tyrosines critical for RNA recognition was replaced
FIG. 4. Amino acids conserved in the RBD of human SLBP and
xSLBP1 but not in xSLBP2. (A) Alignment of the RBDs from the
three different SLBPs. Amino acids conserved or similar between the
human SLBP and the xSLBP1 that differ from the amino acids in
xSLBP2 are highlighted. The residues subjected to mutagenesis are
underlined. (B) Amino acid substitutions made within the RBD of
human SLBP and their effect on the activity of the protein in the 39 end
processing of histone H1t pre-mRNA. The processing efficiency of
each mutant SLBP is reported as a percentage of the processing effi-
ciency of wild-type (WT) SLBP (100%). The values represent the
approximate efficiencies obtained from at least two independent ex-
periments. p, data not shown.
FIG. 5. Substitution of nine amino acids within the RBD of human
SLBP abolishes processing of H1t pre-mRNA but not binding activity
of the protein. The RBD of human SLBP was mutated in three dif-
ferent regions by replacing the amino acids (underlined in Fig. 4) with
the corresponding amino acids found in xSLBP2. (A) Ability of wild-
type (WT) and mutant (indicated above each lane) SLBPs to bind the
RNA stem-loop probe, determined by band shift assay. The probe is
shown in lanes 1 and 6. (B and C) Activity of the nuclear extract (NE)
before (panel B, lane 1) and after (panel B, lane 2; panel C, lanes 1 and
6) depletion of SLBP in processing of the H1t pre-mRNA. The effect
of addition of 100 ng of the different SLBPs (indicated above each
lane) to the SLBP-depleted extract on 39 end processing is shown in
panel B, lanes 3 to 6, and panel C, lanes 2 to 5 and 7 to 9.
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with QC found in xSLBP2 (DR/QC mutation). This substitu-
tion reduced the processing activity on the H1t substrate by
more than 95% (Fig. 5C, lane 3), although it did not affect the
ability of the SLBP to form a stable complex with the stem-
loop (Fig. 5A, lane7). There was approximately a 50% reduc-
tion in processing activity as a result of the IK/LQ mutation,
replacing the IK dipeptide (amino acids 28 and 29) with LQ
found in xSLBP2 (Fig. 5C, lane 4). The DRIK mutant protein
in which all four amino acids were mutated had even less
processing activity than the DR mutant, consistent with an
additive effect of the DR and IK mutations (Fig. 5C, lane 5).
Both IK/LQ (not shown) and DRIK (Fig. 5A, lane 8) efficiently
bound the stem-loop RNA in the band shift assay. Partial or
complete alteration of the RHLQP region revealed that these
five remaining amino acids of the original 9aaR mutation do
not play a major role in the processing activity of human SLBP.
The RHL and QP/KS mutant proteins (Fig. 5C, lanes 8 and 9,
respectively) as well as the RHLQP mutant protein (data not
shown and Fig. 4B) were as active in processing as the wild-
type SLBP.
We combined mutations that alone resulted in no reduction
in processing activity (RHL, QP/KS, QVA, and F48S). The
F48S mutation in conjunction with either the QP/KS or RHL
mutation resulted in about a 50% reduction in processing
activity (Fig. 4B). A similar reduction of SLBP processing
activity was also observed when the QP/KS or RHL mutation
was combined with the other neutral mutation, QVA (Fig. 4B).
Activity of mutant SLBPs in processing is substrate depen-
dent. We have previously reported that there is a region of 20
amino acids in human SLBP immediately downstream of the
RBD that contains residues required for efficient processing of
the histone H1t pre-mRNA (5). Replacing this region with an
unrelated sequence of 20 amino acids found in the same place
in xSLBP2 abolished the ability of human SLBP to support in
vitro processing (5). This mutant was originally designated
20aa but here is referred to as 20aaC. We have thus identified
two relatively short regions of SLBP which are absolutely re-
quired for its activity in processing of H1t pre-mRNA and not
for RNA binding: a cluster of amino acids in the amino-ter-
minal half of the RBD including the DR dipeptide, and the
first 20 amino acids of the C-terminal domain.
We tested the ability of the 9aaR and the 20aaC mutant
proteins, which were inactive in processing of the H1t pre-
mRNA (Fig. 6, top), to process the H2a-614 pre-mRNA. As
discussed above, the SLBP-depleted extract itself can cleave
between 10 and 20% of the H2a-614 pre-mRNA (Fig. 6, bot-
tom, lane 2), consistent with only partial dependence of pro-
cessing of this substrate on SLBP (4, 5, 23, 29). Addition of the
wild-type SLBP to the depleted extract elevated this basal level
of processing to more than 95% (Fig. 6, bottom, lane 3),
restoring the initial processing efficiency of the nuclear extract
(Fig. 6, bottom, lane 1). In the same assay, the 9aaR (Fig. 6,
bottom, lane 4) and 20aaC (Fig. 6, bottom, lane 5) mutant
proteins increased processing efficiency to approximately 90%
and 80%, respectively. The 20aaC mutant protein was repro-
ducibly less active than the 9aaR protein in complementing the
SLBP-depleted nuclear extract. Under the conditions of these
assays, virtually all of the substrate added to the nuclear extract
is stably associated with the mutant proteins, as determined by
using either the SLBP antibody or Ni-nitrilotriacetic acid aga-
rose beads to isolate the SLBP–pre-mRNA complex (not
shown).
We also tested the effect of addition of excess 9aaR and
20aaC mutant proteins to a standard nuclear extract on pro-
cessing of the histone H1t pre-mRNA. The nuclear extract that
had not been depleted of SLBP processed about 40% of the
H1t pre-mRNA (Fig. 7, lane 1). Supplementing this extract
with the exogenous wild-type SLBP (100 ng) increased the
efficiency of processing to over 60% (Fig. 7, lane 2), while
addition of the same amount of the 9aaR protein resulted in
reduction of processing efficiency to less than 10% (Fig. 7, lane
3). A consistently stronger inhibition was caused by addition of
the 20aaC mutant protein (Fig. 7, lane 4), which reduced
processing efficiency to approximately 5%. This dominant neg-
ative effect is similar to that seen when xSLBP2 or 1-2-1 is
added to the processing extract (11) and almost certainly re-
sults from interaction of the substrate with the excess mutant
SLBP rather than with the endogenous SLBP in the extract.
The processing-deficient mutant SLBPs inefficiently recruit
U7 snRNP to the processing complexes. Binding of U7 snRNP
to the substrate pre-mRNA occurs primarily by base pairing
between the 59 end of U7 snRNA and the HDE, located
approximately 10 nucleotides downstream from the cleavage
site. A major, if not the only, function of SLBP in 39 end
FIG. 6. Activity of 9aaR and 20aaC mutant SLBPs in 39 end pro-
cessing is substrate dependent. Processing activity of the nuclear ex-
tract (NE) using the H1t (top) and H2a-614 (bottom) histone pre-
mRNAs before and after depletion of SLBP (lanes 1 and 2,
respectively) and effect of addition of 100 ng of the different SLBPs
(indicated above each lane) to the SLBP-depleted extract on 39 end
processing (lanes 3 to 5). WT, wild type.
FIG. 7. Mutant proteins 9aaR and 20aaC inhibit H1t pre-mRNA
processing when added to a nuclear extract. Lane 1 shows the process-
ing activity of the nuclear extract (NE) using the H1t pre-mRNA as a
substrate; in lanes 2 to 4, 250 ng of each protein was added to the
nuclear extract, and processing of the H1t pre-mRNA was analyzed.
WT, wild type.
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processing is stabilization of the interaction between U7
snRNP and the pre-mRNA substrate (5, 17). SLBP bound to
the stem-loop structure may interact with one of the protein
components of the U7 snRNP providing an additional support
in anchoring the particle to the pre-mRNA. The stabilizing
role of SLBP is critically important in processing of pre-mRNA
substrates, including the H1t pre-mRNA, which contain an
HDE that can form relatively few base pairs with U7 snRNA
(5).
We have previously shown using anti-SLBP that less U7
snRNP coimmunoprecipitates with H1t pre-mRNA than with
H2a-614 pre-mRNA, which contains a nearly perfect HDE (5).
To confirm that this difference did not result from variability in
the efficiency of immunoprecipitation of the pre-mRNA–SLBP
complexes between samples, we carried out the following ex-
periment. The same amounts (50 ng) of either the H1t or the
H2a-614 histone pre-mRNA were mixed with an undepleted
nuclear extract and incubated for 5 min at 22°C, allowing
formation of the processing complexes, but not cleavage of the
substrate to mature mRNA. A small amount of labeled RNA
substrate (100 pg) was added simultaneously with the unla-
beled substrate to monitor the efficiency of immunoprecipita-
tion (control 1 bands in Fig. 8A and B). The reaction mixtures
were subsequently incubated with the SLBP antibody at 4°C,
and complexes assembled on the pre-mRNA were isolated on
protein A-agarose beads. RNA was prepared from the immu-
noprecipitates and then analyzed for the presence of U7
snRNA by Northern blotting (5). During recovery of the RNA
from agarose beads, a small amount of synthetic unlabeled U7
snRNA (containing additional nucleotides at the 59 and 39
ends and therefore migrating slower than the endogenous U7
snRNA) was added to each sample (control 2 bands in Fig. 8A
and B) to monitor the efficiency of ethanol precipitation and
hybridization with the anti-U7 probe. In the presence of the
small amount of radioactive pre-mRNA, only a trace amount
of U7 snRNA was recovered from the agarose beads (Fig. 8A,
lane 1). In this reaction, nearly 100% of the radioactive pre-
mRNA was immunoprecipitated, since SLBP is in molar excess
of the pre-mRNA (control 1 band, Fig. 8A, lane 1). After
addition of 50 ng of unlabeled H1t or H2a-614 pre-RNA, the
efficiency of immunoprecipitation of the radioactive pre-
mRNA was reduced to approximately 40% (Fig. 8A, lane 2) or
30% (Fig. 8A, lane 3), respectively, due to limiting amounts of
the endogenous SLBP. Significantly, in spite of similar effi-
ciency of pre-mRNA immunoprecipitation, the H2a-614 pre-
mRNA bound four- to fivefold more U7 snRNP than the H1t
pre mRNA (Fig. 8A, lanes 2 and 3). We conclude that in
agreement with our previous results (5), these differences are
due to the decreased ability of the U7 snRNP to form a stable
complex with the H1t pre-mRNA.
The most likely explanation for the inability of both the
9aaR and 20aaC mutant proteins to function in H1t pre-
mRNA processing was that each mutation disrupts the inter-
action of SLBP with U7 snRNP and thus causes inefficient
recruitment of the U7 snRNP to the pre-mRNA substrate. We
tested this possibility by directly measuring the ability of the
9aaR and 20aaC mutant proteins to recruit U7 snRNP to
processing complexes assembled on the H1t pre-mRNA (Fig.
8B). H2a pre-mRNA was not used in this assay due to the high
level of SLBP-independent recruitment of U7 snRNA to this
substrate. Approximately 50 ng of unlabeled H1t pre-mRNA
was mixed with the SLBP-depleted nuclear extract alone or
supplemented with either the wild-type or mutant SLBPs. The
amounts of both control RNAs used in this experiment, i.e.,
control 1 RNA (10 pg of the H1t substrate labeled at the 59
end) and control 2 RNA (0.1 ng of cold synthetic U7 snRNA),
were reduced 10 times compared to the previous experiment
(Fig. 8A) to avoid possible interference of a strong radioactive
signal generated by the control bands with the ability to detect
the small amounts of U7 snRNA recruited by the H1t pre-
mRNA. Incubation of the SLBP-depleted nuclear extract con-
taining both labeled and unlabeled H1t pre-mRNA with the
anti-SLBP did not result in immunoprecipitation of detectable
amounts of the pre-mRNA (control 1) or the U7 snRNA (Fig.
8B, lane 1), demonstrating that the sample was free of SLBP.
The essentially complete removal of SLBP from the nuclear
FIG. 8. 9aaR and 20aaC mutant SLBPs have significantly reduced
ability to recruit the U7 snRNP to the histone pre-mRNA. (A) A
nuclear extract was incubated in the absence of unlabeled substrate
(lane 1) or in the presence of 50 ng of either the H1t (lane 2) or
H2a-614 (lane 3) histone pre-mRNA. Anti-SLBP was added, and RNA
prepared from the immunoprecipitate was resolved on an 8% poly-
acrylamide–7M urea gel. U7 snRNA was detected by Northern blot-
ting using an antisense U7 snRNA probe as described in Materials and
Methods. Control 1 is the H2a-614 histone pre-mRNA radiolabeled at
the 59 end, which was added to each reaction (100 pg) to monitor the
efficiency of immunoprecipitation of the unlabeled substrate RNA.
Control 2 (1 ng) represents a synthetic unlabeled U7 snRNA which
contains additional nucleotides at both 59 and 39 flanks and therefore
migrates slower than the endogenous U7 snRNA. This control RNA is
added to each sample prior to ethanol precipitation and allows mon-
itoring of the efficiency of the total RNA recovery and hybridization.
(B) A nuclear extract (NE) was depleted of SLBP (lane 1) and then
supplemented with the indicated baculovirus-expressed proteins (lanes
2 to 4); 50 ng of unlabeled H1t histone pre-mRNA was added to each
extract together with 10 pg of the labeled H1t substrate (control 1).
Anti-SLBP was added, and the immunoprecipitates were processed for
detection of U7 snRNA as in panel A; 0.1 ng of control 2 RNA was
used as a control for precipitation of the RNA. WT, wild type. (C)
Mobility shift assay to determine the binding activity in the control
extract (lane 2), the SLBP-depleted nuclear extract (lane 3), and the
SLBP-depleted nuclear extract supplemented with the baculovirus-
expressed SLBPs (lanes 4 to 6), indicated above each lane. Lane 1
contains the probe alone.
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extract was confirmed by band shift assay (Fig. 8C, lane 3) and
Western blotting with the SLBP antibody (Fig. 3A). The syn-
thetic U7 snRNA (control 2) was detected in this sample at the
expected level, indicating that any immunoprecipitated RNA
was quantitatively recovered during ethanol precipitation (Fig.
8B, lane 1). Addition of 1 mg of the baculovirus-expressed
wild-type SLBP to the SLBP-depleted extract restored binding
activity to the extract (Fig. 8C, lane 4) and allowed immuno-
precipitation of a significant amount of processing complexes
containing U7 snRNP (Fig. 8B, lane 2). The same amount of
the 9aaR mutant protein, although as efficient as the wild-type
SLBP in restoring binding activity to the depleted extract (Fig.
8C, lane 5) and in immunoprecipitating the substrate RNA,
recruited only about 40% of the amount of U7 snRNA re-
cruited by the wild-type protein (Fig. 8B, lane 3). The 20aaC
mutant SLBP was even more impaired in recruiting U7 snRNP
to the H1t pre-mRNA and allowed immunoprecipitation of
25% of the control amount of U7 snRNP (Fig. 8B, lane 4).
Again, addition of the 20aaC protein to the SLBP-depleted
extract restored binding activity to the regular level (Fig. 8C,
lane 6) and resulted in efficient precipitation of the H1t pre-
mRNA (Fig. 8B, lane 4). Thus, reduction in the amount of U7
snRNP immunoprecipitated in the presence of the 20aaC pro-
tein did not result from lower affinity of the mutant SLBP for
the substrate RNA.
DISCUSSION
Human SLBP and one of the two SLBPs isolated from
Xenopus, xSLBP1, are closely related to each other and are
involved in 39 end processing of replication-dependent histone
pre-mRNA in the nucleus. The second form of SLBP in Xe-
nopus, xSLBP2, does not function in processing and is similar
to the other SLBPs only within the RBD (28). Although it
binds to the same RNA target, the RBD of xSLBP2 cannot
substitute for the RBD in the processing-specific SLBPs (11).
Residues of the RBD required for RNA recognition. A min-
imal RBD required for efficient binding to the stem-loop struc-
ture was mapped in human SLBP to a 73-amino-acid region in
the center of the protein, between amino acids 126 and 198
(29). There are two regions in the RBD highly conserved
among different SLBPs, one located between amino acids 10
and 21 and the other located between amino acids 41 and 54.
In addition, the RBD contains a number of conserved aromatic
residues scattered throughout the domain, reminiscent of the
conserved aromatic residues present in the RNA recognition
motif (RRM) (26). Many of these residues in the RRM make
contacts with the single-stranded regions of the RNA and may
be involved in stacking interactions with the bases of the RNA
target. A number of the highly conserved residues in the SLBP
RBD are basic and are always either lysines or arginines. In
several RNA binding proteins, arginine-rich regions in partic-
ular are important in binding and the arginines cannot be
substituted with lysines (1). Basic residues in RNA binding
proteins are also frequently involved in electrostatic interac-
tions with the phosphate groups of the recognized RNA se-
quences. Some of these residues can be either lysine or argi-
nine, but they cannot be changed to alanine without a major
reduction in binding affinity.
Since SLBP has a novel, previously unknown RBD, we
tested whether the same types of rules apply for binding of the
stem-loop RNA by SLBP. Martin et al. showed that changing
the two highly conserved arginines at position 10 and 11 of the
RBD to alanines resulted in complete loss of binding activity
(13), suggesting that the positive charge at both positions was
important. We demonstrated here that changing the same ar-
ginines to lysines (RR/KK mutant) also abolished binding ac-
tivity of SLBP. The guanidinium group of the arginines is likely
to be involved in specific interactions with the phosphodiester
backbone and cannot be replaced by the amino group of the
lysine (1). In addition to the RR/KK mutation, we made a
K19R mutation by replacing the absolutely conserved lysine at
position 19 (also present in SLBPs of the sea urchin, Drosoph-
ila and Chlamydomonas [unpublished results]) with arginine.
In contrast to the RR/KK mutation, replacement of lysine 19
with arginine did not reduce binding affinity of the protein.
However, replacing lysine 19 with alanine resulted in virtually
complete disruption of SLBP binding, suggesting that the pres-
ence of a positively charged residue in this position is essential
for RNA binding. Changing the tyrosines at positions 24 and
27 of the RBD to phenylalanines greatly reduced binding af-
finity, suggesting that there is a major role for the hydroxyl
group as well as for the aromatic ring in RNA binding. Perhaps
the ring of tyrosine stacks against bases of the RNA target and
the hydroxyl group is involved in formation of specific hydro-
gen bonds. In addition, in most SLBPs there are two trypto-
phans (residues 56 and 63) near the carboxyl end of the RBD.
Replacement of these tryptophans with isoleucines completely
abolished binding of SLBP to the stem-loop structure, confirm-
ing the importance of the conserved aromatic residues in se-
quence specific recognition of the RNA target.
Based on these and other studies (13), it seems likely that
binding of SLBP to the stem-loop structure involves a set of
interactions similar to those identified in other RNA-protein
complexes. However, details of these interactions will be
known only after determining the structure of the SLBP-RNA
complex by X-ray crystallography or nuclear magnetic reso-
nance spectroscopy.
Role of the RBD and the C-terminal domain in histone
pre-mRNA processing. The RBDs of vertebrate processing-
specific SLBPs, including mouse and human SLBPs and
xSLBP1 from Xenopus, contain a number of residues that are
not conserved in the processing-deficient xSLBP2. Systematic
substitution of these amino acids in the RBD of human SLBP
with the amino acids found in the same place in xSLBP2
allowed identification of a region of the RBD that plays an
important role in processing. This region includes two key
amino acids, an aspartic acid at position 25 (D25) and arginine
at position 26 (R26), mutation of which makes SLBP almost
completely inactive in H1t pre-mRNA processing. Also impor-
tant is the nearby IK dipeptide, mutation of which results in a
twofold reduction in processing efficiency. The remaining res-
idues conserved in mammalian SLBPs and xSLBP1 but not in
xSLBP2 make a much smaller contribution to the overall pro-
cessing activity of SLBP.
The DR dipeptide is flanked by two tyrosines critical for
RNA binding, Y24 and Y27. The proximity of these residues
may be functionally important. It is likely that SLBP interacts
with another component of the processing machinery only
when it is bound to the histone pre-mRNA. Binding of SLBP
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to its RNA target, partially mediated by the two tyrosines,
could for example trigger some conformational changes in the
RBD, exposing the DR dipeptide thus facilitating its direct
involvement in processing. The Y24F mutant is completely
processing deficient, although it retains the same residual bind-
ing activity as the H41F protein that is capable of supporting
substantial processing of the H2a pre-mRNA. This observation
suggests that the Y24F mutation, adjacent to the DR dipep-
tide, affects both RNA binding and processing.
Immunoprecipitation experiments with the 9aaR mutant
protein support the notion that the DR dipeptide and the
other amino acids of the RBD conserved only in processing-
specific SLBPs are involved in stabilization of the U7 snRNP
on the pre-mRNA. The same role seems to be played by
residues in the 20-amino-acid region immediately C terminal
to the RBD. The 20aaC and 9aaR mutants recruit 4- and
2.5-fold, respectively, less U7 snRNP to the H1t pre-mRNA
than the wild-type SLBP. Consistent with this result, the 20aaC
mutant protein is also less efficient in rescuing processing of
the H2a pre-mRNA in the SLBP-depleted nuclear extract and
has a stronger dominant negative effect on histone H1t pre-
mRNA processing in the presence of the endogenous SLBP.
Combining both the 9aaR and the 20aaC mutations did not
result in further reduction of the amount of immunoprecipi-
tated U7 snRNP nor in further reduction of SLBP activity in
H2a pre-mRNA processing (not shown). We conclude that
both regions of SLBP participate in the same interaction that
results in stabilizing U7 snRNP on the pre-mRNA. The 20aaC
mutation results in more severe disruption of this interaction.
It is likely that the residual processing activity of the 20aaC
mutant SLBP on H2a-614 pre-mRNA is due to the high affinity
of U7 snRNP for the H2a-614 HDE and remaining weak
interactions between the mutant SLBP and U7 snRNP.
Surprisingly, although both 9aaR and 20aaC mutant SLBPs
are inactive in processing of the H1t pre-mRNA, they can still
recruit a significant amount of the U7 snRNP to this substrate
at 4°C. A likely explanation for this observation is the lower
temperature of the immunoprecipitation assay (22° followed
by 4°C) than of the processing assay (32°C). It is possible that
under these conditions, the HDE of the H1t pre-mRNA can
form a relatively strong duplex with the U7 snRNA, which is
not stable at 32°C. This interpretation is supported by previous
studies which demonstrated that lowering the temperature of
incubation favors stronger interaction between the pre-mRNA
and U7 snRNA and decreases the SLBP dependence of in
vitro processing (21).
Requirements for formation of a stable processing complex.
Although the mutant SLBP protein 9aaR containing nine
amino acids of the RBD replaced with the xSLBP2 sequence
was completely inactive in processing of H1t pre-mRNA, it
showed significant activity when the H2a-614 pre-mRNA sub-
strate was used. A similar result was obtained with the 20aaC
mutant protein. These mutants bind the pre-mRNA with the
same affinity as the wild-type SLBP but are impaired in recruit-
ment of U7 snRNP. The same variable effect on processing of
the two substrates was observed with the H41F mutant SLBP
which binds the pre-mRNA weakly. Thus, strong interaction
(either direct or indirect) between the SLBP and U7 snRNP as
well as high-affinity binding of the SLBP to the histone pre-
mRNA are critical for processing of histone pre-mRNAs that
form relatively few base pairs with the U7 snRNA (e.g., the
H1t pre-mRNA) and are less important for processing of pre-
mRNAs that contain a strong HDE (e.g., the H2a pre-mRNA).
Taken together, our results indicate that assembly of a stable
processing complex on the histone pre-mRNA depends on the
additive strength of at least three interactions: RNA-RNA
interactions between U7 snRNA and the HDE, binding of
SLBP to the stem-loop, and interaction of the SLBP-stem-loop
complex with U7 snRNP. A similar requirement for multiple
interactions to stabilize an RNA processing complex is seen in
recognition of the 39 splice site by U2aF65 and U2aF35 which
interact with the polypyrimidine tract and the AG dinucle-
otide, respectively. The presence of a long and uninterrupted
polypyrimidine tract tightly bound by U2aF65 diminishes the
requirement for binding of U2aF35, which is indispensable for
cleavage of the 39 splice sites containing weak polypyrimidine
tracts (32, 33).
SLBP does not interact with the U7 snRNP in the absence of
the pre-mRNA substrate and, as judged by gel filtration chro-
matography, is not found in a complex with other nuclear
proteins (unpublished results). It is likely that the first step in
histone pre-mRNA processing is binding of SLBP to the stem-
loop structure followed by stabilization of the U7 snRNP on
the HDE. The stabilization of the U7 snRNP may be achieved
by direct interaction of the SLBP-RNA complex with one of
the proteins of the U7 snRNP. However, it is possible that
there is a yet unknown component of the processing machinery
which interacts with both SLBP and U7 snRNP and provides a
bridging link between the two processing factors, resulting in
stable association of the U7 snRNP with the pre-mRNA. One
approach to identifying this unknown component may be to
screen for proteins that interact with the SLBP/SL complex
using a modification of the yeast two-hybrid system. These
studies are in progress.
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